Tirzepatide activates GLP-1 and GIP receptors to reduce appetite and slow gastric emptying, creating a caloric deficit through reduced intake
These medications are not a quick fix and should form part of a comprehensive treatment plan under medical supervision
In white adipose tissue, blocking NNMT elevated resting calorie burn, decreased adiposity, and improved insulin sensitivity in rodent models, independent of diet or activity changes (Kraus et al., Nature Medicine )
For laboratory research use, the safest sources are US-based suppliers that publish independent, batch-specific Certificates of Analysis and ship domestically to protect temperature-sensitive material
My colleagues, Tim Richards and Glynn Tonsor, and I will further explore these questions in future work